Samuel Meignan

9PUBLICATIONS
67CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 29, 2025
Novel Diffuse Midline Glioma-on-Chip Recapitulating Tumor Biophysical Microenvironment to Assess the Heterogeneity of Response to Therapies.

Lisa Terrassoux, Calypso Hazard, Agathe Laratte

|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.

Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt

|May 05, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.

Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt

|Oct 14, 2022
A Bloody Conspiracy- Blood Vessels and Immune Cells in the Tumor Microenvironment.

Lisa Terrassoux, Hugo Claux, Salimata Bacari

|Nov 13, 2021
H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines.

Andria Rakotomalala, Quentin Bailleul, Clara Savary

Pageof 2